ABHA
WOW99
chat.png

8433808080

lnew-lang-01.svg
EnglishHindi
cart.png0

Prescription Required

Eleftha 150mg Injection

by Intas Pharmaceuticals Ltd
Trastuzumab (150mg)

₹6295

Eleftha 150mg Injection

Introduction to Eleftha 150mg Injection

Eleftha 150mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Safety Advice for Eleftha 150mg Injection

  • High risk
  • Moderate risk
  • Safe
safetyAdvice.iconUrl

Eleftha 150mg Injection may cause excessive drowsiness with alcohol.

safetyAdvice.iconUrl

Eleftha 150mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

safetyAdvice.iconUrl

Eleftha 150mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

safetyAdvice.iconUrl

It is not known whether Eleftha 150mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

safetyAdvice.iconUrl

Eleftha 150mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Eleftha 150mg Injection may not be needed in these patients. Please consult your doctor.

safetyAdvice.iconUrl

There is limited information available on the use of Eleftha 150mg Injection in patients with liver disease. Please consult your doctor.

How Eleftha 150mg Injection works

Eleftha 150mg Injection is a recombinant IgG1 monoclonal antibody. It works against the HER2 (human epidermal growth factor receptor protein) receptors which are responsible for the over-proliferation of cancer cells in breast cancer and stomach cancer cells. It destroys the cancer cells by inhibiting HER2. It also inhibits various cancer-causing downstream signaling pathways.

How To Use Eleftha 150mg Injection

  • Your doctor or nurse will give you this medicine. Kindly do not self administer.

Side Effects Of Eleftha 150mg Injection

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

Similar Medicine Of Eleftha 150mg Injection

Herclon 150mg Injection 1s

Herclon 150mg Injection 1s

₹17390

View Detail
Canmab 150mg Injection 1ml

Canmab 150mg Injection 1ml

₹21431

View Detail
Hervycta 150 Injection

Hervycta 150 Injection

₹20300

View Detail
Neuzumab 150mg Injection 7.2ml

Neuzumab 150mg Injection 7.2ml

₹22288

View Detail
Hertraz 150mg Injection 1s

Hertraz 150mg Injection 1s

₹19500

View Detail
Vivitra 150mg Injection 1s

Vivitra 150mg Injection 1s

₹24669

View Detail
Trasturel 150mg Injection

Trasturel 150mg Injection

₹24200

View Detail
Hermab 150mg Injection

Hermab 150mg Injection

₹19500

View Detail
Hersima 150mg Injection

Hersima 150mg Injection

₹19133

View Detail

FAQ's on Eleftha 150mg Injection

What are the serious side effects of Eleftha?

There are various side effects related to Eleftha such as sore throat, fever, chills, excessive tiredness, pale skin, nosebleeds, and other unusual bruising or bleeding. One can also experience stomach pain, seizures, hallucinations, muscle cramps, and spasms. Along with that, nausea or vomiting, loss of appetite, fatigue, rapid heart beat, discoloration of urine decreased amount of urine, difficulty in urinating, pain when urinating, and other signs of infection can also be observed with the use of Eleftha. You should call your doctor immediately if you notice any such symptoms.

How long should Eleftha be taken?

Patients with early breast cancer should take Eleftha for 1 year or until disease recurs, whichever occurs first. It is not advised to extend the treatment beyond 1 year in patients of early breast cancer.

Can Eleftha be given to HER2 negative cancer patients?

No, Eleftha cannot be given in patients with HER2 negative cancer cells. Eleftha belongs to class of monoclonal antibody. It binds selectively to a protein called human epidermal growth factor receptor 2 (HER2). HER2 is found, in large amounts, on the surface of some cancer cells. When Eleftha binds to HER2, it stops the growth and spread of the cancer cells. Therefore, it is only effective in HER2 positive patients (in which HER2 is present) and will not be beneficial for HER2 negative patients (in which HER2 is not present).

Is fasting required before administering Eleftha?

No, fasting is not required before administering Eleftha. It should be given under the guidance of a doctor who is experienced in giving cancer chemotherapy and should be given only by a healthcare professional.

How is Eleftha given, intravenously or intramuscularly?

There are 2 different formulations available for administration of Eleftha, one is given as an infusion into a vein (intravenous infusion) and the other is given as an injection under the skin (subcutaneous injection). It is important to check the product labels to ensure that the correct formulation is being given as prescribed. Eleftha intravenous formulation is not for subcutaneous use and should be given as an intravenous infusion only. Your doctor may consider switching your Eleftha intravenous treatment to Eleftha subcutaneous treatment (and vice versa) if considered appropriate for you.

How frequently heart investigations are required?

Heart investigations should be performed at the starting of the treatment. It should be repeated every 3 months during treatment and every 6 months after the discontinuation of treatment until 24 months from the last administration of Eleftha. Those patients who already have heart-related problems will require investigations every 12 weeks.

Why has my doctor advised for investigations of heart?

Eleftha when used with anthracycline class of anti-cancer medicines (eg doxorubicin) may adversely affect your heart. Hence, your doctor needs to check the health of your heart initially before starting treatment and during treatment.

How long after Eleftha therapy can I get pregnant?

Women of child-bearing age should use effective contraception during Eleftha therapy and for 7 months after completing the treatment. You can plan your pregnancy after 7 months of treatment with Eleftha.

Prescription Required

Eleftha 150mg Injection

by Intas Pharmaceuticals Ltd
Trastuzumab (150mg)

₹6295

Eleftha 150mg Injection

Discover the Benefits of ABHA Card registration

Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!

Create ABHA
heart-logo.png

Download the app

black-playstore.svgwhite-playstore-01.svg

DawaaDost

Our Policies

Our Services

Knowledge Base

Fetured Categories

DawaaDost

Our Policies

Our Services

Knowledge Base

Featured Categories

Customer Care

© 2025 DawaaDost. All rights reserved. In compliance with Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945, we don't process requests for Schedule X and other habit forming drugs.

whatsapp-icon